Login / Signup

Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial.

Olivia J HoferChristopher Joel Dorman McKinlayThach S TranCaroline A Crowther
Published in: The Australian & New Zealand journal of obstetrics & gynaecology (2020)
Maternal body size is not associated with infant morbidity after ACS exposure. Dose adjustment for women with higher BMI is not required.
Keyphrases
  • birth weight
  • pregnancy outcomes
  • pregnant women
  • weight gain
  • acute coronary syndrome
  • body mass index
  • clinical trial
  • study protocol
  • phase iii
  • preterm birth
  • open label
  • weight loss